`
Monday, 26 June 2017

Clinical Research News

  • US-based ERT expands in Japan

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2013

    Singapore: ERT, a US-based service provider to biopharmaceutical organizations, medical device companies and contract research organizations (CROs), has established a fully-owned subsidiary...Read more

  • International Clinical trials day Special: Asia's clinical trials landscape

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 20 May, 2015

    Singapore: Clinical trials were once undertaken largely in the West. However many Asian countries are now emerging as top destinations for clinical trials. For more than a decade, the emerg...Read more

  • NextDocs expands customer list by more than 10%

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2013

    Singapore: NextDocs, the global leader in compliance solutions for regulated industries, announced that it has expanded its client roster by more than 10 percent over the past six months, a...Read more

  • GVK BIO eyes top spot among Asian CROs

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2014

    Singapore: In a bid to race ahead to be among the top three Asian clinical research organizations in the next five years, India's Hyderabad-based contract research company GVK Biosciences (...Read more

  • Japan's IDA selects OmniComm Systems' clinical data management solution

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 16 Jun, 2015

    OmniComm Systems Inc., a provider of clinical data management technology, announces the selection of the company's Promasys EDC by Integrated Development Associates (IDA), a Tokyo-based Pan...Read more

  • CROs and pharma support 'Bring Your Own Device' approach for clinical studies: ICON survey

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 04 Jul, 2016

    Singapore: ICON, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has conducted a research that revealed that...Read more

  • WuXi signs to be exclusive supplier to Lee Pharma

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2015

    Singapore: WuXi PharmaTech's Laboratory Testing Division (LTD) has partnered with Lee Pharma as an exclusive supplier of laboratory testing services for portfolio of discovery and IND/NDA p...Read more

  • QPS to deploy preclinical data management system, Pristima Suite

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2012

    Singapore: QPS Taiwan, a global preclinical toxicology services provider, has been selected to deploy Pristima Suite, which is Xybion's premier preclinical application. QPS will leverage P...Read more

  • Tarceva tablets with Nexavar show no improvement

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2012

    Singapore: A phase III trial evaluating the efficacy and safety of the addition of Tarceva (erlotinib) tablets to Nexavar (sorafenib) tablets did not show improvement in overall survival of...Read more

  • NIH launches clinical trial focused on HIV-related CV disease

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2015

    Singapore: Researchers have begun enrolling participants in to a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiov...Read more

  • BeiGene to build its first cGMP facility in Suzhou BioBAY

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2015

    Singapore: China's BeiGene, a clinical-stage biopharmaceutical company focused on developing molecularly-targeted and immuno-oncology drugs for the treatment of cancer, recently announced t...Read more

  • Intercept-Sumitomo completes liver cirrhosis drug's phase II trials

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2015

    Tokyo: Intercept Pharmaceuticals Inc has announced the results of a 72-week phase II dose ranging trial of obeticholic acid (OCA), a lead FXR agonist, in adult patients with nonalcoholic st...Read more

  • PPD partners with CISYS LifeSciences

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 08 Sep, 2015

    Pharmaceutical Product Development(PPD) and CISYS LifeSciences has announced PPD's implementation of Sequence WebEAS, a new Web-based event adjudication system, through a collaboration betw...Read more

  • QPS CRO opens office in China

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 03 Oct, 2012

    Singapore: QPS Holdings, a leading full-service clinical research organization, announced the launch of its QPS Qualitix China Office, built to service the unique needs of the Chinese biop...Read more

  • Cellmid gets positive data in midkine study

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 23 Jan, 2013

    Singapore: Cellmid has completed its first in-life diabetic nephropathy study with the company's anti-midkine antibodies (MKAb) in a mouse model of the disease. Two of Cellmid's proprietar...Read more

  • Sanofi's dengue vaccine candidate shows positive results

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 12 Sep, 2012

    Singapore: Sanofi Pasteur, the vaccines division of Sanofi has published clinical study results of its dengue vaccine candidate in the online publication of The Lancet. The results of the t...Read more

  • The evolving clinical trial landscape of Asia

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2015

    Singapore: At a recent Pharma CI Conference & Exhibition Asia held in Tokyo, Citeline, a leading research authority on clinical trials reported that clinical trials in East Asia have in...Read more

  • Quest Life Sciences receives WHO notice: Reports

    Clinical Research |  News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2015

    Singapore: According to reports, Quest Life Sciences has received a 'notice of concern', or NoC from the World Health Organisation (WHO) for 'critical' lapses and deviations from standards ...Read more

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls